RAPT Therapeutics, Inc. (RAPT) Return on Capital Employed (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Return on Capital Employed for 5 consecutive years, with 1.07% as the latest value for Q3 2024.
- Quarterly Return on Capital Employed fell 44.0% to 1.07% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 1.07% through Sep 2024, down 44.0% year-over-year, with the annual reading at 0.64% for FY2023, 25.0% down from the prior year.
- Return on Capital Employed hit 1.07% in Q3 2024 for RAPT Therapeutics, down from 1.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.3% in Q3 2021 to a low of 1.07% in Q3 2024.
- Historically, Return on Capital Employed has averaged 0.56% across 5 years, with a median of 0.44% in 2023.
- Biggest five-year swings in Return on Capital Employed: rose 15bps in 2022 and later crashed -53bps in 2024.
- Year by year, Return on Capital Employed stood at 0.47% in 2020, then increased by 26bps to 0.35% in 2021, then dropped by -10bps to 0.38% in 2022, then tumbled by -101bps to 0.77% in 2023, then tumbled by -39bps to 1.07% in 2024.
- Business Quant data shows Return on Capital Employed for RAPT at 1.07% in Q3 2024, 1.02% in Q2 2024, and 0.89% in Q1 2024.